biomarin
The BioMarin Financial Development Program is a 24-month initiative designed to accelerate growth as a finance and business leader within the biotech industry. Participants gain hands-on experience through two 12-month rotations across various finance functions, including corporate finance, R&D finance, and financial reporting. The program combines on-the-job learning with coaching, specialized training, and leadership development to prepare individuals for advanced career opportunities.
Headquarters
San Rafael, California, United States
Company Size
1001-5000 employees
Founded
1997
BioMarin Pharmaceutical is a global biotechnology company that researches, develops, and commercializes therapies for rare genetic and lysosomal storage diseases. The company has brought medicines to market for conditions such as achondroplasia and severe hemophilia A and focuses on innovative modalities—including gene therapies and biologics—to address high unmet medical needs. BioMarin partners with clinicians, regulators, and patient communities to advance treatments from discovery through global regulatory approval and patient access.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for biomarin.
biomarin didn’t post a salary, so this is our estimate from similar listings.
Future Finance Leader Program
honeywellaerospace.us
Future Finance Leader Program
Honeywell Aerospace
Finance Rotation Program - Financial Analyst
Atmus Filtration Technologies
Lead Finance Rotational Program
Wabtec
Junior Officer Leadership Program
GE HealthCare
Financial Rotational Program
oraclecloudinfrastructure